GOUT CHRONIC

Clinical trials for GOUT CHRONIC explained in plain language.

Never miss a new study

Get alerted when new GOUT CHRONIC trials appear

Sign up with your email to follow new studies for GOUT CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New gout pill shows promise in large trial

Disease control Completed

This Phase 3 study tested AR882, a drug designed to lower uric acid levels in people with gout. Over 800 participants took either a 50 mg or 75 mg dose of AR882 or a placebo daily for 12 months. The main goal was to see if AR882 could bring uric acid below 6 mg/dL at 6 months, wh…

Matched conditions: GOUT CHRONIC

Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC

GOUT CHRONIC

Get alerted when new GOUT CHRONIC trials appear

New gout pill shows promise in large trial